Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

141.42
BATS BZX Real-Time Price
As of 10:37am ET
 +0.95 / +0.68%
Today’s Change
95.14
Today|||52-Week Range
147.45
+25.51%
Year-to-Date
No recent news for Abiomed Inc.

Today’s Trading

Previous close140.47
Today’s open141.27
Day’s range141.04 - 141.95
Volume3,721
Average volume (3 months)301,288
Market cap$6.2B
Dividend yield--
Data as of 10:37am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+37.65%
Earnings growth (this year)+56.89%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+35.13%
P/E ratio121.0
Price/Sales12.56
Price/Book13.57

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+0.11+0.15%
WSTWest Pharmaceutical ...-0.32-0.33%
MASIMasimo Corp+0.07+0.08%
IARTIntegra LifeSciences...+0.61+1.14%
Data as of 10:38am ET, 06/28/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.42
Annual revenue (last year)$445.3M
Annual profit (last year)$52.1M
Net profit margin11.70%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts